|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/185 | |||
| A61K 31/352 | |||
| A61P 25/16 | |||
| A61P 25/28 | |||
| A61P 25/00 | |||
| A61P 9/10 |
| (11) | Number of the document | 2726069 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12731151.2 |
| Date of filing the European patent application | 2012-06-29 | |
| (97) | Date of publication of the European application | 2014-05-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2012/051540 |
| Date | 2012-06-29 |
| (87) | Number | WO 2013/005017 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201111261 | 2011-07-01 | GB |
| (72) |
IUVONE, Teresa, IT
DI MARZO, Vincenzo, IT
GUY, Geoffrey, GB
WRIGHT, Stephen, GB
STOTT, Colin, GB
|
| (73) |
GW Pharma Limited,
Sovereign House, Histon Cambridge CB24 9BZ,
GB
|
| (54) | CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS |
| CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS |